Case Report
Immune-Mediated Necrotizing Myopathy Manifesting after Five Years of Statin Therapy
Table 2
Follow-up laboratory values.
| | Lab | Values |
| | Anti-HMGCR level | 101 U (strongly positive) | | ANA level | 1.087 U (slightly positive) | | NXP-2 antibody | Negative | | TIF1-γ antibody | Negative | | /140 antibody | Negative | | PL-7 antibody | Negative | | EJ antibody | Negative | | Jo-1 antibody | Negative | | Smith/RNP antibody | 69 U (moderately positive) | | SSA 52 antibody | Negative | | Fibrillarin antibody | Negative | | CCP antibody | Negative | | SAE1 antibody | Negative | | ANA titer | Negative | | MDA5 antibody | Negative | | MI-2 antibody | Negative | | PL-12 antibody | Negative | | OJ antibody | Negative | | SRP antibody | Negative | | Ku antibody | Negative | | PM/Scl 100 antibody | Negative | | SSA 60 antibody | Negative | | Rheumatoid factor | Negative | | CK | 3369 U/L |
|
|
ANA, antinuclear antibodies; CK, creatine kinase; HMGCR, 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase.
|
